Application no. and date | 99928769.1 (espacenet) (Federated) (European Patent Register), 19990617 | Patent/reg. no. and date | DK/EP 1086076, 20041222 | Publication date | 20010328 | Priority no. and date | US 90094 P, 19980619 | EP pub. no. and date |
EP 1086076 20010328 | Effective date | | Applicant/owner | VERTEX PHARMACEUTICALS INCORPORATED, 50 Northern Avenue Boston, MA 02210, US | Applicant ref. no. | 121821 | Inventor | SHERRILL, Ronald George,
Glaxo Wellcome Inc., Five Moore Drive,
P.O. Box 13398
Research Triangle Park, NC 27709, US, SPALTENSTEIN, Andrew,
Glaxo Wellcome Inc., Five Moore Drive,
P.O. Box 13398
Research Triangle Park, NC 27709, US, FURFINE, Eric Steven,
Glaxo Wellcome Inc., Five Moore Drive,
P.O. Box 13398
Research Triangle Park, NC 27709, US, ANDREWS, Clarence W., III,
Glaxo Wellcome Inc., Five Moore Drive,
P.O. Box 13398
Research Triangle Park, NC 27709, US, LOWEN, Gregory, Thomas, P.O. Box 315
Williamsburg, VA 23187, US, HALE, Michael, R., 42 Sunset Road
Bedford, MA 01730, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | C07C 303/00 | Title | Sulfonamidinhibitorer af aspartylprotease | Int. application no. | US1999013744 | Int. publication no. | WO1999065870 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|